Item 7.01 Regulation FD Disclosure.

On April 25, 2022, Inhibrx, Inc. (the "Company") issued a press release announcing its new Scientific Advisory Board for INBRX-101. The full text of the Company's press release regarding this announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K.

The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.



 Exhibit No.      Description
99.1                Press Release issued by Inhibrx, Inc. on April 25, 2022

© Edgar Online, source Glimpses